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Mimicry of Native Peptide Antigens by the Corresponding
Retro-Inverso Analogs Is Dependent on Their Intrinsic
Structure and Interaction Propensities1
Deepak T. Nair,* Kanwal J. Kaur,* Kavita Singh,* Paushali Mukherjee,* Deepa Rajagopal,*
Anna George,* Vineeta Bal,* Satyajit Rath,* Kanury V. S. Rao,† and Dinakar M. Salunke2*
Retro-inverso (ri) analogs of model T cell and B cell epitopes were predictively designed as mimics and then assayed for activity
to understand the basis of functional ri-antigenic peptide mimicry. ri versions of two MHC class I binding peptide epitopes, one
from a vesicular stomatitis virus glycoprotein (VSVp) and another from OVA (OVAp), exhibit structural as well as functional
mimicry of their native counterparts. The two ri peptides exhibit conformational plasticity and they bind to MHC class I (H-2Kb)
similar to their native counterparts both in silico and in vivo. In fact, ri-OVAp is also presented to an OVAp-specific T cell line
in a mode similar to native OVAp. In contrast, the ri version of an immunodominant B cell peptide epitope from a hepatitis B virus
protein, PS1, exhibits no structural or functional correlation with its native counterpart. PS1 and its ri analog do not exhibit
similar conformational propensities. PS1 is less flexible relative to its ri version. These observed structure-function relationships
of the ri-peptide epitopes are consistent with the differences in recognition properties between peptide-MHC vs peptide-Ab binding
where, while the recognition of the epitope by MHC is pattern based, the exquisitely specific recognition of Ag by Ab arises from
the high complementarity between the Ag and the binding site of the Ab. It is evident that the correlation of conformational and
interaction propensities of native L- peptides and their ri counterparts depends both on their inherent structural properties and
on their mode of recognition. The Journal of Immunology, 2003, 170: 1362–1373.
T he reverse synthesis of a peptide using D-amino acids re-sults in a peptide analog wherein the direction of the pep-tide bonds is reversed and the N- and the C-termini are
interchanged. The retro-inverso (ri)3 transformation produces a
structural isomer that maintains the original stereochemical con-
figuration at all the chiral centers but reverses the sequence. Native
peptide and its ri analog on superimposition show that the carbon-
yls of the peptide bonds in the native molecule are present over the
peptide bond amides in the ri molecule and vice versa. The super-
imposition also shows that the identical side chains overlap in the
two versions, although the polarity of the peptides is exactly op-
posite. These transformations lead to a peptide showing a high
degree of topochemical equivalence with the parent peptide. The
synthesis of ri peptides has been widely used in peptidomimetic
drug design to create molecules resistant to naturally occurring
peptidases (1, 2). As the natural proteases are stereospecific, they
are unable to cleave the peptide bond in retro-D analogs, leading
to higher bioavailability and consequently removing the need for
high doses. This topochemical mimicry of side chain residues by
retro-inversion has been exploited to generate cross-reactive anti-
peptide Abs and to design various peptidomimetic drugs (3).
The structural features of molecular recognition involving dif-
ferent systems, although exploit similar noncovalent forces, are
often unique and have distinct characteristics enabling diverse
specificities. Recognition of T and B cell peptide epitopes provide
an interesting example of the molecular recognition by two differ-
ent proteins of the immune system: MHC and Abs (4). The rec-
ognition involving MHC molecules with T cell epitope peptides of
diverse sequences is achieved by restricting the sequence speci-
ficity to a few anchoring residues. Peptides bind MHC in an ex-
tended conformation and the length of the peptides that can bind to
MHC is nearly constant. In contrast, antipeptide Abs follow an
entirely different strategy of Ag recognition. In many cases, the
peptides derived from soluble proteins are recognized in confor-
mations resembling those found in the original protein. Abs have
perhaps the highest specificity, although not necessarily the highest
affinity, where several individual side chains in the peptide Ag
cannot be replaced without substantial loss in binding affinity. In
peptide-Fab complexes, usually only 7–10 residues are visible in
the Ab binding pocket. The exquisitely specific recognition of Ag
by Ab stems from the high complementarity in size and shape
between the Ag and Ab binding site, and by the formation of
specific hydrogen bonds and charged interactions with the Ag.
Examples of both the failure and success of retro-D analogs of
immune epitopes to exhibit antigenic mimicry are present in the
literature (1). However, the exact parameters that influence the
competence of a retro-D analog remain to be completely eluci-
dated. To find a plausible solution for this structural puzzle, ri
analogs of model T cell and B cell peptide epitopes were designed
and assayed for activity. The T cell epitopes chosen were octam-
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ers, [RGYVYQGL] (vesicular stomatitis virus glycoprotein pep-
tide; VSVp) and [SIINFEKL] OVA; OVAp) (5), derived from a
vesicular somatitis virus protein and the OVA protein, respectively.
These antigenic peptides have been studied extensively and the struc-
tures of their complexes with the MHC class I (MHCI) molecule,
H-2Kb, have been elucidated (6, 7). The B cell epitope used is PS1, a
15-mer peptide (HQLDPAFGANSTNPD) derived from the large sur-
face Ag of hepatitis B virus. An exhaustive study of the murine im-
mune response against PS1 has shown that the Abs in the secondary
response are unanimous in their specificity for the four-residue stretch
of PS1, DPAF (8). The structures of PS1 bound to three distinct cog-
nate mAbs from the secondary response have been determined (9,
10). It is evident that all the three Abs recognize a common immu-
nodominant epitope incorporating primarily DPAF stretch of the pep-
tide Ag. The Abs show conformational convergence on binding, al-
though they display dissimilar binding-site structures in the absence of
the Ag. The epitope also exhibits conformational similarity when
bound to each of these Abs although the peptide Ag was otherwise
flexible. The observed conformational convergence in the epitope and
the Ag-binding site was facilitated by the plasticity in the nature of
interactions.
Due to the dichotomy associated with the structural features in
antigenic recognition, a comparative analysis of structure and in-
teraction preferences of the ri analogs of these T cell and B cell
epitopes has been conducted and functionally assessed using bio-
chemical and immunological assays. The correlation of conforma-
tional propensities of the native L peptides and their ri counterparts
depends on the inherent structural properties of the individual pep-
tides. The T cell epitopes VSVp and OVAp, which both adopt the
extended conformation, exhibit similar conformational propensi-
ties in L and ri forms, and the ri analogs of VSVp and OVAp are
functionally active through similar molecular interactions with
their receptor. In contrast, the B cell epitope PS1 shows distinct
conformational propensities in the ri version. Consequently, the ri
analog of the B cell epitope was found to be unable to bind to any
of the anti-PS1 Abs. Overall, it appears that the degree of corre-
lation in conformational propensities—and hence functional
equivalence—between native L peptides and their ri counterparts
are influenced by the inherent structural properties of the individ-
ual peptides. Additionally, the degree of leeway permitted for suc-
cessful recognition also appears to have a bearing on the appear-
ance of successful antigenic mimicry by ri analogs.
Materials and Methods
Analysis of molecular stereochemistry
The Ramachandran plots were made using Procheck from the CCP4 suite
of programs (Warrington, U.K.). The  and  angles for the native peptide
were exchanged and the handedness of the amino acids was changed to get
the ri versions of the three peptides. The Ramachandran plots were also
computed for the ri analogs of the three peptides. The plots for native and
ri versions of the same peptide were compared.
Molecular dynamics analysis
The native peptide conformations and their ri analogs were subjected to
molecular dynamics simulation. The peptide was initially soaked in a water
box of appropriate size with periodic boundary conditions and then sub-
jected to molecular dynamics. All simulations were conducted at 300 K for
500 ps. The system was allowed to equilibrate for the first 50 ps and
conformations were written out for the remaining 450 ps at an interval of
4.5 ps. The trapped conformations were compared with the starting con-
formation in terms of root mean square deviation (rmsd) in the position of
C and all atoms. The frequency distributions of the calculated rmsds for
both native and ri peptides were plotted and compared.
Docking
The ri analog was initially manually docked into the H-2Kb binding groove
while monitoring intermolecular energies using the DOCKING module of
INSIGHTII (San Diego, CA). The conformation of the native peptide was
used as a guide. Next, the complex of MHC peptide was subjected to
conjugate gradient minimization until convergence using the DISCOVER
module of INSIGHTII. No explicit hydration shell was defined as the pep-
tide docking in the binding site was being optimized. Instead, distance-
dependent dielectric constant was used, and all energy-based computations
were done using a consistent valence force field. The hydrophobic surfaces
of the MHCI-peptide complexes were computed and compared using IN-
SIGHTII. The van der Waal interactions between peptide and the MHC
molecule (distance cutoff 4 Å) were listed using CONTACT program of the
CCP4 suite. The solvent accessible surface area, which gets buried on
complexation, was calculated using HOMOLOGY module of INSIGHTII.
Peptide synthesis, purification, and characterization
VSVp, OVAp, PS1, and their ri analogs were synthesized by solid phase
method using an automated peptide synthesizer model 431A (Applied Bio-
systems, Foster City, CA), using standard F-moc methodology. Although
the wild-type MHCI-specific T cell epitopes had free N- and C-termini, ri
peptides were amidated at C-terminal and acetylated at N-terminal unless
explicitly mentioned. For ease of reference the residue numbers are iden-
tified by their positions in the native L peptide throughout. The peptides
were cleaved from the resin by treatment with trifluoroacetic acid/thioani-
sole/phenol/water/1,2-ethanedithiol in ratio as recommended by Applied
Biosystems. The crude peptides were purified using C-18 column
(Deltapak-100 Å, 15 , spherical, 19  300 mm; Waters, Bedford, MA)
and peptide purity was verified using C-18 analytical column (Deltapak-
300 Å, 15 , spherical, 7.8  300 mm; Waters). The peptides were char-
acterized by molecular mass measurement using single Quadruple mass
analyzer (Fisons, Loughborough, U.K.).
MHCI-peptide binding and T cell stimulation
The H-2b cell lines RMA and RMA-S were used for assaying the binding
of peptides and their analogs to MHCI. RMA-S is deficient in the cytosol-
to-ER peptide transporter TAP; therefore, empty MHCI molecules come to
the surface and stay there for very short periods, leading to a reduction in
the cell surface MHCI levels. Addition of an MHCI-binding peptide from
outside stabilizes this cell surface MHCI on RMA-S cells and increases the
net levels of MHCI. Thus, the binding of a given peptide to MHCI is
indicated by its ability to increase the equilibrium levels of MHCI on the
surface of RMA-S cells. Therefore, peptides were incubated for 24 h with
RMA-S cells (1  106 cells/ml) at various concentrations as indicated, and
H-2Kb levels on the cells were determined using the mAb Y-3, followed
either by anti-mouse Ig fluorescein and flow cytometry (Elite EPS; Coulter,
Hialeah, FL), or by anti-mouse Ig -galactosidase and color development
with chlorophenol red -D-galactopyranoside (Roche, Nutley, NJ) read at
570 nm. Any increase in MHCI level on RMA-S observed at each peptide
concentration was expressed as a percentile of the MHCI level on wild-
type RMA cells.
The OVAp H-2b-specific T cell transfectoma B3 was used to examine
cross-reactivity of the OVAp analogs at the TCR level. B3 T cells (1 105
cells/well) were stimulated with titrated concentrations of various peptides
in the presence of C57BL/6 spleen cells (1  105 cells/well) as APCs in
triplicate cultures in 200 l DMEM with 10% FCS, antibiotics, L-glu-
tamine, and 0.05 mM 2-ME in 96-well flat-bottom plates (Falcon, Franklin
Lakes, NJ). IL-2 levels induced were estimated by bioassays on culture
supernatants collected 24–36 h later by using them to stimulate the IL-2-
dependent cell line CTLL-2 (1  104 cells/well) for 24 h, followed by
pulsing of the plates with 0.5 Ci/well of [3H]thymidine (NEN, Boston,
MA) for 12–16 h to measure the proliferative response. Data are shown as
mean cpm  SEM in triplicate cultures.
ELISA
Plates were coated with the PS1CT3 peptide (8) (1 g/well) in 100 l of
carbonate buffer (pH 9.6) at 4°C for overnight. Subsequently, wells were
blocked with 300 l of 1% gelatin in PBS (pH 7.2) at 37°C for 2 h. Then,
100 l of the appropriate dilution of mouse monoclonal ascites was added
and incubated at 37°C for 1.5 h. After washing, bound Ab was detected
with HRP-labeled secondary Ab (37°C, 1 h) followed by color develop-
ment with o-phenylenediamine as chromogen. Absorbance was measured
at 490 nm. Initially, experiments were conducted to find out the working
dilution of the monoclonal ascites for each Ab. Once the working dilution
was established, the competition ELISAs were conducted. The plates were
coated with PS1CT3 peptide. The diluted mouse monoclonal ascites were
incubated with the ri-PS1 and native PS1 peptides before assaying for PS1
binding.
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Results
ri versions of the T cell epitopes, VSVp and OVAp, exhibit
conformational correlation with their native counterparts
It was expected that a ri-peptide analog corresponding to a given
sequence should adopt a conformation similar to that of the cor-
responding L peptide (11). Therefore, we built the conformational
models of ri analogs of VSVp and OVAp (called ri-VSVp and
ri-OVAp). To generate the appropriate conformational model of
the ri analog, initially, the sequence of the original L-peptide was
reversed and the handedness of the residues was changed to D.
According to the basic theory of ri mimicry, the topochemical
equivalence is achieved because the side chains in the two versions
have the overlapping conformations. To achieve such an overlap of
the side chain for a particular residue, the N-C bond in native
peptide should overlap with the C-C bond in the ri version and
vice versa. For this to occur, the dihedral angles  and  in the
native peptide would have to necessarily be equal to the dihedral
angles  and  in the ri analog, respectively. Thus, to achieve
conformational equivalence between the two versions, the back-
bone dihedral angle values in the L peptide have to be interchanged
in the ri analog for corresponding residues. Also, to be consistent
with change in handedness and to achieve the overlap between the
side chains, the dihedral angle 1 in the case of ri-peptide would
have to be 1  180° with respect to the corresponding residue of
L peptide. These transformations were conducted on the H-2Kb-
bound conformations of the OVAp and VSVp peptides. The final
models obtained from these transformations for the ri-OVAp and
ri-VSVp peptides were superimposed onto the parent L peptides
(Fig. 1). Most of the side chains of different residues of the native
peptide overlap in space with the identical side chains on the ri
version, but it is evident that the complete superimposition with the
native peptide (as seen in the MHCI-bound conformation) is still
not achievable.
The distribution of the backbone dihedral angles,  and , for
the native and ri versions were compared using the Ramachandran
plot (12) in the case of the T cell epitopes. In both cases, the
distribution of  and  angles for the native peptide and its ri
analog are localized in the equivalent regions of the Ramachandran
plot as can be seen from Fig. 2. The  and  angles in the case of
the native peptides are present in the core regions for -strands. In
the case of the ri versions of the peptides, these dihedral angles are
localized to the core and allowed regions corresponding to the
-strands. The plots show that when the ri peptide is made to adopt
a conformation which overlaps that of the native peptide in its
bound form, the backbone dihedral angles are all in the allowed
regions and also localized in the same area on the map as that of
the native peptide. Thus, it is energetically possible for the ri ver-
sions of the two T cell epitopes to assume a conformation that
mimics that of the native peptide in its MHC-bound state. In other
words, the ri analog of each T cell epitope can potentially act as the
functional mimic of the native peptide.
The N- and C-termini of the native peptides VSVp and OVAp
have been known to play a significant role in binding to MHCI
molecule H-2Kb (13). Reversal of the termini—as happens in the
ri-peptide—could preclude stabilization of these analogs in the
MHC-binding groove due to change in the nature of the charge at
the ends; therefore, it is necessary to account for the charge rever-
sal. Earlier attempts to design ri mimics of T cell epitopes by
chemically converting the carboxylate group into amido and the
amino group into carboxylate had failed to give desired binding
(14). Therefore, we made an attempt to remove the repulsive in-
teractions that might arise due to the charge reversal by simply
neutralizing the charges on both the end groups—through acety-
lation of the amino group and the amidation of the carboxylate
group.
It is anticipated that for an ri analog to functionally mimic the
corresponding L peptide, it should exhibit the conformational pro-
pensities of the L peptide. To compare the propensities of the two
peptides in solution, molecular dynamics simulation (15) was con-
ducted in both the cases. The molecular dynamics analyses show
that the distribution of the backbone rmsd values is comparable in
the case of both native L and ri versions of each of the T cell
epitopes (Fig. 3). The distribution is bimodal and the average of
the rmsd values is also very close for the native and ri versions in
the case of each of these peptides. The mode values for the rmsds,
in case of OVAp and VSVp, were 1.92 and 1.72 Å, and for the
corresponding ri versions were 2.02 and 2.07 Å, respectively.
Therefore, the extent of change with respect to the starting con-
formation that the two versions undergo in solution is the same,
indicating an inherent similarity in conformational flexibilities.
The analyses of the Ramachandran plots have already shown that
the conformations of the ri versions of the T cell epitopes that
mimic the bound conformation of the native peptides are energet-
ically possible. Thus, based on the similar conformational vari-
ability in solution as observed in molecular dynamics simulation
and the accessible conformational space as inferred from the Ra-
machandran plot analyses, it is anticipated that the ri analogs
should be able to adopt conformations similar to those of the cor-
responding native peptide, in case of the above two T cell epitopes.
FIGURE 1. Structural comparisons of L and ri peptide analogs of the T
cell epitopes. The structural alignment of the native and ri versions for
VSVp (A) and OVAp (B) are shown. The native conformation is shown in
black and the ri peptide in gray in stereo pairs.
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In other words, in the same environment—such as the binding site
groove of the cognate MHC molecule—the ri peptides can show
conformational similarity with their parent native peptides. Con-
sequently, the ri peptides might be able to functionally mimic the
biological activity of their parent native L peptides.
Interactions of the two ri peptides (ri-VSVp and ri-OVAp) with
MHCI (H-2Kb) resemble those of their native counterparts
Because the analyses of dihedral angles and conformational pro-
pensities showed that ri analogs could potentially mimic the native
T cell epitope peptides, immunological assays were designed to
test for this activity. The ri versions of OVAp and VSVp (ri-OVAp
and ri-VSVp, respectively) with blocked N- and C-termini were
synthesized and assayed for binding to the MHCI molecule H-2Kb.
Both ri-OVAp and ri-VSVp, which had the N-terminal acetylated
and the C-terminal amidated, bind with H-2Kb (Fig. 4). The dose-
dependent binding of ri-OVAp is comparable to that of OVAp,
while ri-VSVp binds with slightly more efficiency than VSVp. We
had anticipated that the N- and the C-terminal unblocked versions
of ri-OVAp and ri-VSVp should not be active as the changed po-
larity of the two ends might significantly affect binding. Indeed,
this is what was observed when the free peptides were tested for
MHCI binding (Fig. 4).
Structural comparisons of MHCI molecules bound to cognate T
cell epitopes have shown that the MHCI binding groove exhibits
the presence of distinct structural pockets occupied by residues
present at particular positions on the peptide epitope. To visualize
whether the binding mode observed for native peptide in the crys-
tal structures holds true for the ri analogs also, ri-OVAp and ri-
VSVp were docked into the binding site of the H-2Kb molecule.
The docking studies divulge that the mode of binding in the MHCI
groove is similar for both native and ri versions of OVAp and
VSVp peptides. Comparison of the computer-docked models of
the ri-peptide-H-2Kb complexes and the crystal structures of the
corresponding native L peptides complexed with H-2Kb reveal that
the same peptide residues are present in the corresponding struc-
tural pockets (Fig. 5). Conformations of the peptide side chains
overlap to a great extent and the backbones show an extended
structure in the bound forms (Fig. 1). In the case of the MHCI
molecule, the side chain and backbone conformations of the resi-
dues which form the groove also show considerable overlap.
FIGURE 2. Conformational analyses of T cell epitopes in L and ri forms. The Ramachandran plot for VSVp and ri-VSVp (A) and OVAp and ri-OVAp
(B) are shown. The core regions are shown in dark gray, allowed regions in gray, and generously allowed regions in light gray. The disallowed regions
are shown in white.
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The mimicry between the ri peptides and their corresponding
native L counterparts is evident from the contacts between the
MHCI molecule and the bound peptides. Apparently, common res-
idues of the MHCI molecule interact with the corresponding res-
idues on the two versions of the same peptide as seen in Tables I
and II. In case of the VSVp:H-2Kb complex, a marginally higher
number of contacts was observed compared with the case of the
ri-VSVp:H-2Kb model. The number of contacts formed is substan-
tially higher in case of the residues Arg1P, Gln6P, and Leu8P. The
acetyl group present forms a significant number of interactions
with the MHCI molecules. For the OVA peptide, it was observed
that the number of contacts formed is nearly equal in case of the
native and ri versions. The blocking acetyl group present forms
many contacts raising the effective number of contacts in case of
ri-OVAp slightly more than those of OVAp. Thus, the ri peptides
and the corresponding native L peptides show similar contacts and
the acetyl group of the N-terminal is closely interacting with the
MHC molecule in both the cases.
The solvent accessible surface area buried on complexation is
similar in the case of the two versions of the VSV peptides, VSVp
and ri-VSVp, but shows some degree of difference in the case of
the OVA peptides, OVAp and ri-OVAp (Table III). The solvent
accessible surface area buried in the case of the ri peptides is
higher. One reason for this could be that the blocking acetyl and
amide groups are not present in the case of the native peptide. The
docking studies indicate that the ri versions of the VSVp and
OVAp can bind the H-2Kb molecule as competently as the corre-
sponding native peptides.
The in silico analyses suggested that the mode of binding of the
ri versions of the two T cell epitopes resemble their L counterparts.
To validate this experimentally, we designed two analogs of the
ri-VSVp and tested for MHCI binding. As evident from the crystal
structure of VSVp-H-2Kb complex (6), the residues of the peptide
critical for H-2Kb binding are P3 (Tyr), P5 (Tyr), and P8 (Leu).
These residues fit into the interior of the H-2Kb molecule with no
appreciable surface exposure. In contrast, the side chains of P1
(Arg), P4 (Val), and P6 (Gln) are exposed on the surface of the
complex. If the ri-VSVp interacts similar to the VSVp, then the D
residues corresponding to the P3, P5, and P8 positions should be
critical for H-2Kb binding and those corresponding to P1, P4, and
P6 positions should not be particularly important for this binding.
We designed two analogs of ri-VSVp with L residue substitutions
FIGURE 3. Conformational propensities of
T cell epitopes in L and ri forms. The frequency
distribution of rmsd values during a 500-ps mo-
lecular dynamics simulation run for VSVp and
ri-VSVp (A) and OVAp and ri-OVAp (B) in an
aqueous box.
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at positions P1 (L-Arg1-ri-VSVp) [ri-(L)RGYVYQGL] and P8 (L-
Leu8-ri-VSVp) [ri-RGYVYQG(L)L]. As expected, the L-Arg1-ri-
VSVp analog shows H-2Kb binding comparable to that of the ri-
VSVp and the binding is almost completely abrogated in case of
the L-Leu8-ri-VSVp analog in H-2Kb stabilization assays using
RMA-S cells (Fig. 4). Thus, the experimental data of side chain
interactions is consistent with the in silico interpretations.
The ri-OVAp and its rationally designed analogs functionally
resemble their corresponding native L counterparts
The stereo drawings of the hydropathy features on the surfaces of
the OVAp:H-2Kb and ri-OVAp:H-2Kb complexes as presented to
the TCR are shown in Fig. 6. The almost precise correspondence
of the surface features between the two cases is evident. The com-
plexes of H-2Kb with native and ri versions of OVAp would thus
present a similar surface for the cognate TCRs to recognize. The
topological features and the localization of the regions of similar
hydrophobicity are remarkably alike for the two versions of each
peptide. Hence, it can be anticipated that the H-2Kb:OVAp and
H-2Kb:ri-OVAp complexes will bind to the same TCR with com-
parable affinity. This is indeed the case, as seen from Fig. 7. It was
evident that ri-OVAp and OVAp, the two versions of the peptide,
possess similar abilities to stimulate an OVAp-specific T cell line.
The analysis of MHCI-peptide recognition has shown that res-
idues at certain critical positions on the peptide make a major
contribution to the free energy of binding. These positions, P3,
P5/P6, and P8, are known as the anchor positions and the residues
at these positions are called anchor residues. Mutational studies
involving substitutions at these anchor positions are reported in the
literature for OVAp (15). The functional consequences of these
mutations, in terms of the nature of the mutation, have been ex-
tensively analyzed by T cell activation assays. To experimentally
verify further that the mode of binding of ri-OVAp resembles that
of the OVAp, the ri versions of some of these OVA peptide ana-
logs were tested for biological activity using T cell activation as-
says, because recognition of peptide by peptide-specific T cells is
dependent on both MHC binding and TCR recognition. These N-
and the C-terminal protected ri-peptide analogs corresponding to
the rationally designed changes at the critical positions were syn-
thesized and assayed for T cell stimulation activity. It was ob-
served unambiguously that for those L peptide analogs, which
showed biological activity, their ri analogs were also active. In the
case of those L peptide analogs found inactive, the ri versions were
also inactive. The substitution by similar residues in these anchor
positions does not reduce the activity significantly, but substitution
by completely different amino acid results in substantial loss in
activity. For example, at P3 change of Ile to Tyr leads to loss of
activity. At P5, Phe to Tyr results in not a significant loss, but Phe
to Ala results in complete loss of activity. Similarly, at P8, Leu to
Val results in small loss of activity, but the change Leu to Ala leads
to complete loss of activity (Fig. 7). Also, the peptide having N-
and C-terminal ends free, which provides exactly opposite charge
in the ri version, does not show any activity at all. These obser-
vations are consistent with the activity profiles of the correspond-
ing L analogs (16).
ri versions of the B cell epitope PS1 exhibits no conformational
or functional correlation with its native counterpart
The 15-residue immunodominant peptide, called PS1, from hepa-
titis B virus surface Ag has been extensively characterized in terms
of immune response and Ab recognition (8–10, 17, 18). To test
whether the mimicry observed in case of the T cell epitopes also
exists in case of the B cell epitopes, analogous computational and
biochemical experiments were conducted using PS1. A 7-mer an-
alog (QLDPAFG) of PS1 whose ends are blocked has been ob-
served to completely inhibit the binding of PS1 to anti-PS1 Abs
(data not shown). As far as Ab recognition is concerned, the 7-mer
possesses all the functional properties of the 15-mer PS1, but
would be less intensive to handle computationally. Therefore, all
further computational and biochemical studies were conducted
with this 7-mer peptide referred to as PS1 and the corresponding ri
analog as ri-PS1.
Unlike the T cell epitopes, PS1 does not adopt an extended
conformation when bound to any of the three independent mAbs
with which it has been crystallized (9, 10). The stretch DPAF,
which also represents an immunodominant epitope, adopts a
-turn conformation. In case of the native 7-mer analog, compar-
ison of the Ramachandran plot shows that the distribution of  and
 angles is localized to distinctly different regions for native and ri
residues (Fig. 8A). Although the native peptide occupies the core
and allowed regions corresponding to -helix, some residues of ri
analog occupy the allowed and generously allowed regions corre-
sponding to the left-handed helices while others are found in the
disallowed regions. Thus, in the case of the ri-PS1 peptide, the
FIGURE 4. MHCI binding of the wild-type T cell
epitopes OVAp and VSVp and of their ri analogs.
H-2Kb levels on the cell surface were estimated for
RMA cells and RMA-S cells incubated overnight with
various concentrations of the indicated peptides. Re-
sults are shown as increase in MHCI levels on RMA-S
cells as a percentage of the levels seen on RMA cells.
Data are representative of five independent experi-
ments. The ri-SIINFEKL(free) and RGYVYQGL(free)
have free N- and C-termini. Wild-type L peptides also
have free N- and C-termini. L amino acid is indicated
by L in bracket preceding that residue.
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conformation which would be a topochemical equivalent of the
bound PS1 conformation is energetically unfavorable. Hence, the
plots indicate that there might be a drastic difference between the
functional properties of the native and ri versions of PS1.
To check this hypothesis molecular dynamics simulations of the
peptides were conducted and it was seen that there is a consider-
able difference between the frequency distribution of backbone
rmsds between native and ri analog (Fig. 8B). Additionally, the
mode value for the native peptide was0.8 Å, whereas that for the
ri analog was 1.3 Å. The ri analog exhibits a higher variation in its
conformation than the native L peptide. Thus, the extent of con-
formational change that the two versions undergo in solution—
compared with starting conformation—are considerably different
indicating heterogeneous conformational flexibilities. The DPAF
epitope in the native peptide adopts a -turn conformation on Ab
binding. It is stereochemically not possible for ri-PS1 to adopt a
conformation similar to that of the bound PS1. This is evident from
the Ramachandran plot analysis; the equivalent conformation for
the ri analog lies in the disallowed region of the Ramachandran
plot. Additionally, different extents of variability in the conforma-
tion, exhibited by the ri and the native peptides, imply heteroge-
neous conformational propensities for the two peptides. Differ-
ences in the conformational propensities might preclude the
formation of this -turn and consequently result in ri-PS1 not bind-
ing to anti-PS1 Abs. Hence, it is possible that the ri analog of PS1
might not be functionally active.
ri version of the B cell epitope PS1 does not bind to the anti-PS1
mAbs, consistent with their structural differences. The ri peptide
analog was assayed by ELISA for its ability to compete with the
coated native PS1 peptide to bind to the Abs. It was evident that
the ri peptide shows negligible inhibition of binding to PS1 in case
of all the three anti-PS1 Abs, PC283, PC282, and PC287 (Fig. 9).
In the control experiments, the native 7-mer L peptide could show
dose-dependent inhibition of the three anti-PS1 Abs binding to
PS1. Thus, the ri version of the B cell epitope PS1 is not func-
tionally active unlike the T cell epitopes VSVp and OVAp.
Discussion
It was anticipated that a ri peptide analog would adopt conforma-
tion similar to that of the corresponding L peptide. However, as is
FIGURE 5. Comparison of MHCI-native and MHCI-ri peptide com-
plexes. The residues of H-2Kb, which interact with VSVp and ri-VSVp (A)
and with OVAp and ri-OVAp (B), are shown here. The MHCI-ri peptide
complexes are shown in black and the MHCI-native peptide complexes are
shown in gray in stereo pairs.
Table I. Interaction table for native and ri versions of the VSV peptide
with the H-2Kb molecule
Peptide
Residue
Interacting Residues
With L Peptide
Interacting Residues
With ri Peptide
Arg1P Y159(4) Y159(4)
Y171(5) Y171(6)
K66(2) K66(4)
W167(7) W167(5)
R62(1) R62(1)
E163(6) E63(3)
L5(1) Y59(4)
T163(2)
Y7(8)
Gly2P Y159(1) Y159(4)
E63(3) E63(3)
Y7(3)
K66(4)
Tyr3P Y159(6) Y159(7)
L156(7) L156(5)
Q114(2) Q114(1)
R155(11) R155(13)
E152(4) E152(5)
N70(3)
Val4P N70(2) N70(3)
R155(3) R155(2)
K66(1) K66(2)
Tyr5P N70(6) N70(7)
S99(4) S99(2)
Y116(3) Y116(3)
F74(5) F74(6)
Q114(2) Q114(3)
V97(1) V97(1)
S73(2)
Gln6P E152(7) E152(6)
R155(2) R155(2)
D77(1)
Y116(1)
W147(3)
R155(1)
W147(2)
Gly7P D77(2) D77(2)
W147(2) S73(3)
Leu8P D77(6) D77(10)
T143(9) T143(3)
W147(1) W147(3)
L81(1) L81(3)
Y84(5) Y116(1)
K146(6)
Y116(1)
Ace Y84(5)T143(5)
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evident from our studies, based on the antigenic peptides, this need
not be the case. Conformations of the ri peptide analogs—arrived
at by the basic conformational transformations instrumental in ri
mimicry—do not superimpose very well, as seen in case of both
the T cell epitopes, OVAp and VSVp. Nevertheless, the - an-
gles of the native and the ri versions of these peptide Ags lay in the
allowed regions of the Ramachandran plot. Additionally, both the
native as well as the ri versions of these peptides exhibit substan-
tial conformational plasticity. Therefore, it can be inferred that the
conformational space of each of the native and ri peptides is mu-
tually accessible, even though they do not have identical struc-
tures. In contrast, the ri version of the B cell epitope PS1 exhibits
no significant conformational correlation with its native counter-
part. The native conformation of PS1 is such that the correspond-
ing equivalent conformation of the ri analog does not belong to the
allowed region of the Ramachandran plot. It is also evident that
while the native PS1 does not show any significant conformational
plasticity, the ri peptide analog of PS1 exhibits substantial flexi-
bility. No significant change with respect to the starting confor-
mation in PS1 during molecular dynamics simulation was ob-
served, perhaps due to the stable intramolecular hydrogen bonding.
In contrast, ri-PS1 showed significant conformational variability.
Thus, the B cell epitope exhibits low structural plasticity and dif-
ferent conformational propensities for the native and the ri ver-
sions of the epitope.
Indeed, the functional data with regard to the immune epitopes
analyzed in this study are consistent with the corresponding struc-
tural comparisons. Although ri-VSVp and ri-OVAp exhibit bind-
ing to H-2Kb, the MHCI that recognizes the two T cell epitopes,
the ri version of the B cell epitope PS1 does not bind to the anti-
PS1 mAbs. Because the conformational space of the T cell
epitopes was found to be accessible to their corresponding ri an-
alogs, it was expected that the ri analogs would adopt a confor-
mation similar to that of their native counterparts while binding to
MHCI. In that case, ri-VSVp and ri-OVAp ought to exhibit similar
interactions while binding to MHCI molecule and while being pre-
sented to the TCR leading to functional mimicry. This is indeed the
case, as was evident from the molecular docking analyses involv-
ing dominant conformations of the ri T cell epitopes (ri-VSVp and
ri-OVAp) into the peptide binding site of H-2Kb and the T cell
activation by ri-OVAp and its designed analogs. The binding in-
teractions in the refined computer-docked models of the retro pep-
tides (ri-OVAp and ri-VSVp) with H-2Kb substantially resemble
the interactions of OVAp and VSVp with H-2Kb in the crystal
structure. Also, the designed analogs of ri-OVAp resemble the
corresponding native T cell epitope analogs in their T cell activa-
tion profile, implying that the functional role of different side
chains of the ri peptide were equivalent to the corresponding L
peptide. Thus, the ri mimics of the T cell epitopes used here exhibit
pattern-based recognition involving a set of anchor residues sim-
ilar to those defined for the corresponding native peptide while
binding to MHCI molecule.
Even though the functional ri mimics could be designed for the
T cell epitopes OVAp and VSVp, the same was not possible for the
B cell epitope, PS1. One of the reasons for this could be the dif-
ferences in the bound conformation of the peptide. The T cell
epitopes and PS1 show an extended structure and a -turn, respec-
tively, when bound to their cognate receptors. This could imply
that it would be easier for a ri analog to successfully mimic the
extended conformation rather than a folded conformation with ex-
tensive intramolecular interactions. This is a plausible hypothesis
considering that the extended conformation is more likely to be
flexible and would provide substantial leeway in optimizing com-
mon interactions. However, there are two cases where it has been
shown that the ri analog does possess turn-like structures similar to
the native peptide (19, 20). In one of the cases, the presence of a
number of glycine residues (three of nine) could be imparting flex-
ibility to the two versions of the peptide allowing the conforma-
tional propensities to overlap (19). Overall, although the nature of
the bound structure of the native peptide could be important in
determining the success or failure of ri-antigenic mimicry, it would
certainly not be the only criterion.
Table II. Interaction table for native and ri versions of the OVA
peptide with the H-2Kb molecule
Peptide
Residue
Interacting Residues
with L Peptide
Interacting Residues
with ri Peptide
Ser1P W167(7) W167(3)
Y171(3) Y171(4)
E63(5) E63(3)
Y159(4) Y159(3)
K66(2) T163(2)
Ile2P Y159(2) Y159(5)
E63(1) E63(5)
K66(6) K66(3)
E24(5) E24(4)
Y45(1) N70(4)
K66(2)
Ile3P Y159(11) Y159(17)
R155(2) S99(2)
L156(1) Q114(3)
L156(1)
Asn4P N70(6) N70(2)
R155(6) R155(6)
Phe5P N70(7) N70(7)
Y116(3) Y116(2)
F74(3) F74(5)
Q114(3) Q114(4)
V97(1) V97(1)
S73(1)
Glu6P R155(2) R155(2)
E152(4) E152(8)
D77(1) Y116(2)
W147(4)
A150(2)
Lys7P D77(4) D77(2)
S73(5) S73(1)
W147(3)
K146(1)
V76(3)
Leu8P T80(1) T80(1)
D77(3) D77(10)
T143(9) T143(2)
K146(9) L81(3)
Y84(4) W147(1)
T143(7)
Ace Y84(3)
K146(3)
T80(1)
Y84(6)
T143(4)
Table III. Solvent accessible surface area buried in case of the native
and ri- versions of the VSV and OVA peptide
Complex
Solvent Accessible Surface Area That Is
Buried on Complex Formation
Peptide MHCI
VSV 1096 814
ri-VSV 1122 796
OVA 715 979
ri-OVA 1167 832
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Before our studies, many groups have reported design of ri mim-
ics of immune epitopes. There are several instances of the ri ver-
sion of a B cell epitope exhibiting similar immune response prop-
erties as those of the native peptide, while there are certain other
instances where ri analogs did not show functional mimicry (21,
22). A critical aspect of designing ri analog of any peptide is the
interchange of the N- and the C-termini of the peptide. In case of
the MHCI molecule H-2Kb, for example, a significant role has
been attributed to the N- and C-termini of the native peptides in
binding to H-2Kb (13). The positive and negative charges at the N-
and C-termini have been exploited to form stabilizing polar inter-
actions with oppositely charged surfaces on the MHC surface. It
was anticipated that the reversal of the termini could preclude sta-
bilization of these analogs in the MHCI-binding groove due to
repulsion between similarly charged surfaces. Therefore, it was
considered necessary to compensate for this structural feature. Ear-
lier attempts to design ri-T cell epitopes, involving VSVp, by
chemically converting the carboxylate group into amide and the
amino group into carboxylate through a major modification at D-
Leu residue—replacing it with isobutyl malonic acid—had failed
to give desired binding (14), perhaps due to the formation of ra-
cemic mixture during modification. In the present study, this issue
has been addressed by simply neutralizing the charges on both the
end groups acetylation of the amino group and the amidation of the
carboxylate group. It was expected that any chemical modification
of the termini would abolish some stabilizing hydrogen bonds
made with the class I molecules but it would prevent repulsive
polar interactions. There is one example of a naturally occurring T
cell epitope with a chemical modification neutralizing the charge
of the -amino group. The MHCI molecule, H-2 M3, has been
shown to specifically bind to N-formylated mitochondrial and bac-
terial peptides (23). The fact that the blocked peptides ri-OVAp
and ri-VSVp could successfully bind H-2Kb reveal that this is a
simple and elegant solution to the problem of end modification.
FIGURE 7. T cell activation by the T cell epitope OVAp, its ri coun-
terpart, and its rationally designed ri analogs. The responses of the OVA-
specific MHCI-restricted T cell line B3 to C57BL/6 (H-2-b) macrophages
are shown in titrating doses of various peptides indicated. The data are
representative of three independent experiments. The native SIINFEKL
and ri-SIINFEKL(free) have free N- and C-termini.
FIGURE 6. Comparison of surface features of
H-2Kb-OVAp and H-2Kb-ri-OVAp complexes.
The Connolly surface is shown in stereo, colored
according to hydrophobicity for H-2Kb-OVAp
(A) and H-2Kb-ri-OVAp (B). In the color spec-
trum used, blue indicates maximum hydrophilic-
ity and red indicates maximum hydrophobicity.
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The manner in which B cell and the T cell epitopes are recog-
nized by the immune system could also be relevant in the design
of the immune epitope mimics. MHCI molecule recognizes pep-
tides of diverse sequence with the sequence specificity being re-
stricted to a few anchoring residues (24). The T cell epitope
peptides bind MHCI in an extended conformation with a very
specific set of critical residues that act as anchors suggesting
that the side chain interactions are more crucial for MHCI-
peptide recognition and the presence of appropriate residues at
the anchor positions, rather than the backbone interactions, de-
fines the binding specificity. In other words, both the MHCI
molecule which recognizes the peptide epitope and the TCR to
which the MHCI peptide complex is presented exhibit a degree
of degeneracy in peptide recognition. The higher level of con-
formational flexibility associated with T cell epitope described
above combined with the pattern-based recognition property in
MHCI binding, and presentation to TCR makes it possible for
the ri peptide to adopt a functionally competent conformation
and thus successfully bind to the MHCI molecule as well as
activate the TCR.
Plasticity in recognition of T cell epitopes by the immune sys-
tem appears to be instrumental in the successful antigenic mimicry
exhibited by the ri analogs. In contrast, the recognition of the pep-
tides by antipeptide Abs appears to follow a different strategy. The
FIGURE 8. Conformational propensities of PS1 in L and ri forms. A, Ramachandran plot analysis for B cell epitopes. The Ramachandran plot for PS1
and ri-PS1 are shown here. The core regions are shown in dark gray, allowed regions in gray, and generously allowed regions in light gray. The disallowed
regions are shown in white. B, Molecular dynamics simulation analysis. The frequency distribution of rmsds during a 500-ps molecular dynamics simulation
run for PS1 and ri-PS1 in an aqueous box is shown here.
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recognition is based on complementarity between Ag and the ma-
tured Ab as the binding interactions are optimized during the Ab
response. No specific pattern of interactions exists in this case. The
exquisitely specific recognition of Ag by Ab arises from the high
complementarity in shape and charge between the Ag and the Ab-
binding site. Thus, in the case of the peptide epitope-Ab interac-
tion, optimization of complementarity between the peptide and the
Ab appears to be a key feature. During maturation, Ab optimizes
the paratope through somatic mutations, which are driven by a
template of the paratope-stabilized conformation of the peptide
epitope. In that sense, although a small number of residues are
involved, it is hard to define any universal anchoring pattern.
For the B cell epitope PS1 it must be remembered that the mAbs
tested were part of a highly specific immune response focused
on the immunodominant DPAF epitope. Because stepwise Ab
maturation could lead to the presence of Abs of diverse levels
of specificity, it is possible that in some cases ri mimicry can be
observed. However, it must be said that the low level of plas-
ticity in the epitope conformation and epitope-paratope inter-
actions can significantly lower the possibility of functional B
cell epitope mimicry.
Although our data provide clear evidence for the functional abil-
ity of ri peptide analogs of MHCI-binding epitopes, it is as yet
unclear how complete the L and ri peptide equivalence would be in
vivo. Thus, the next question for us would be whether our in vivo
oligoclonal SIINFEKL-specific CD8 T cell response is efficiently
recalled and/or triggered with full functional equivalence by ri-
SIINFEKL. If this indeed were the case, it would lead to possible
usage of long-lived ri peptides in the design of antiviral vaccines.
However, our present data also indicate that the rate of success of
using such ri peptides for B cell epitope mimicry may not be very
high. Furthermore, the issue of MHC class II (MHCII)-peptide
interactions also becomes interesting in light of our observations.
It appears that the interaction of the MHCII-specific T cell epitopes
with MHCII molecules depends substantially more on the peptide
backbone and less on the side chains unlike in case of MHCI (26).
Although the MHCI as well MHCII-specific T cell epitopes show
similar conformational preferences, the above observation, in con-
junction with our data, would suggest that ri-peptide analogs of
MHCII-specific peptides may not be able to function as well as
they can for MHCI. However, this would require experimental
validation.
To summarize, while the T cell epitopes to MHCI could be
mimicked by a ri analog, the highly specific binding of PS1
through a -turn conformation could not be mimicked by a simi-
larly designed ri analog. This is not surprising as the peptides
interact with their corresponding protein receptors in a variety of
different modes (25, 27), and that ought to be taken into account
while designing peptidomimetics. Even though the postulated te-
nets for ri mimicry appear to be satisfied by B cell epitopes in
earlier reports (28), the low level of plasticity in the epitope con-
formation and epitope-paratope interactions may have been the
reason for not achieving the functional mimicry. In contrast, the
inherent conformational flexibility in the peptide and the plas-
ticity of MHCI-peptide interactions facilitated the functional
mimicry in case of the two T cell epitopes. The observations
made in this study highlight the differences in the mode of
recognition for T cell and B cell epitopes consistent with the
perception that while the key features of T cell epitope are
pattern and plasticity, those of the B cell epitope are specificity
and complementarity.
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